Login

Understand Stock

Sign in or create a free account to unlock 10 years of data, build your watchlist, create alerts and more.

Sign in

$CTNM

$17.05 +$0.35 (2.1%)

Deep Research with AI Research

$CTNM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

$CTNM 8-K/A SEC Filings

Filed On	Filing
14 Aug 2024	8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure -Strengthened Board and management with appointments of experienced biotech leaders Troy Ignelzi, Sarah Boyce, John Healy and Kristina Haeckl -

Loading...